1. Introduction {#s0005}
===============

Many diseases caused by Methicillin-Resistant Staphylococcus aureus (MRSA) declare serious wide-world health challenge not less than 2 million morbidities and mortality human rate per year ([@b0075]). Because of MRSA infections, about more than 80.000 severe infections which increase the rate of death up to 11.000 cases ([@b0020]). In Europe, nearly 5.000 deaths cost 700 million\$ which MRSA infections no longer stays in hospital and the estimated cost for this regard for each case exceeded 34.000\$ ([@b0085]). Based on that, acceptable and urgent techniques are currently required to elaborate on new strategies to maximize the benefits of existing conventional antibiotics against bacterial strains ([@b0255]).

There are some of the commonly tested antibiotics against MRSA, such as chloramphenicol, tetracycline, penicillin, aryl thiazoles, and linezolid (LD) behind vancomycin which considered one of the last-resort drugs but the efficacy is not proper. Frequent misuse, a rapid decrease of plasma concentration, and insufficient dose at the infection specific sites are one of the limitations of traditional dosage methods which largely contribute to the resistance between antibiotics and drugs ([@b0065], [@b0090]). So, a new strategy as a powerful call for penetrating and protecting these antibiotics is being fastened in the literature.

Recently, nanoantibiotic systems based on bio-polymeric structures are being explored to tackle the resistance of antimicrobial problems and find out a true solution for the enhancement of the interaction between antibiotics and bacterial cell walls. Further nanosystems are included micelles ([@b0070]), nanoemulsion ([@b0095]), liposomes ([@b0190]), and nano valve ([@b0045]), and biopolymeric sponge nanocarrier ([@b0145]). Amongst them, polymeric nanocarrier increasing stability and improving the limitations of osmotic shocks related to liposomes and such reported polymers had excellent drug release behavior ([@b0130], [@b0185]).

It is well-known that naturally occurred chitosan (CN); the deacetylates product form chitin structure (β-- (1--4)-linked D-glucosamine) and is a pioneer amongst polysaccharides in the world for many applications ([@b0200] [@b8000]). CN has exceptional characteristics due to its biocompatibility, non-toxicity, the merit of eco-friendly, biodegradability, and significant antibacterial activity. However, assigning to its solubility under acidic condition (pH \~ 4.0) and not appropriate in the common organic solvent, it is seldom to be used in many fields ([@b0025], [@b0140]). These drawbacks may be overcome by suitable chemical modification to enhance functionality, solubility, loading/release, and crystallinity. There are several adopted works introduce different function moieties to CN such as proper Schiff base modification ([@b0015]), crosslinking ([@b0100]), carboxymethylation ([@b0250]), and grafting ([@b0175]) for pharmaceutical applications. However, during the last decades\' limited research in the area of delivery of antibiotics using modified CN. Thus, conjugation of CN with other bio-related compounds produces desirable properties in the resulting biofunctionalized polymer with viable applications. 3,5-dinitrosalicylic acid (3,5-DA) amongst different salicylic acid derivatives is used for the detection of reducing sugars owing to its feature as a colorimetric biomedical assay and including different groups --OH, --COOH, and --NO~2~ in the structure ([@b0110]). According to our survey, there is only paper introduces 3,5-DA with CN in the presence of manganese ferrite, and this green combination used for adsorption and photodegradation of pollutants under visible light ([@b0215]). The synthetic procedures achieve size reduction and the material synthesis was activated by hydrogen peroxide to compact the adsorption behavior.

The antibiotic oxazolidinones (e.g. Linezolid (LD)) are a new family of an antimicrobial with a unique mechanism of action, superior tissue penetration, and excellent pharmacokinetic index ([@b0230]). It is the popular choice of antibiotics for MRSA bacterial treatments besides vancomycin since 2001. Nevertheless, antimicrobial combination therapy may be efficient synergistic to provide broad-spectrum coverage, prevent the emergence of resistant mutants, and obtain a synergy between both antimicrobial agents.

Hereby, the research work was aimed to develop nanoantibiotic biomaterial based on the functionalized chitosan with 3,5-dinitro salicylic acid (CN/DA) loaded with linezolid (LD) as nanoantibiotic system (LD\@CN/DA). The designed nanocomposite was examined to evaluate the in-vitro release of LD. The bearing CN/DA encouraging in size reduction to prolong its chemical stability, prevent agglomeration, and increase the charge density at the surface by functionality. A series of physicochemical tools were used to characterize the prepared powerful microwave synthesis of CN/DA. This combination is aggressive against baneful MRSA and other selected different test microbes namely: *Staphylococcus Aureus* ATCC 6538 (G + ve), *Enterococcus faecalis* ATCC 29212 (G + ve)*, Escherichia Coli* ATCC 25922 (G-ve), *Candida Albicans* ATCC 10231 (yeast) and *Aspergillus Niger* NRRL A‑326 (fungus). As such trend is mandatory to employ nano-formulation based on the green principles to overcome antimicrobial drug resistance owing to biocompatibility and cytotoxicity which also tested.

2. Materials and methods {#s0010}
========================

2.1. Microwave fabrication of CN/DA nanostructure {#s0015}
-------------------------------------------------

About 1 g of CN (75--85% deacetylated, 50,000--190,000 Da, Sigma-Aldrich) was dissolved in 50 mL of distilled water containing 0.1 mL of glacial acetic acid (analytical grade) with moderate stirring. Then after, 1.51 g of DA (Sigma-Aldrich) was mixed with consecutive 9.11 mL DMF (analytical grade) and 7.75 mL formaldehyde (analytical grade, 37--40%). The later content was added to the CN solution for 30 min in a 250 mL round flask to produce a yellow slurry solution. All the reaction solution was transferred to microwave reactor with PTFE tubes (WX-4000) with the following parameters: 40% stirring rate, 1000 W, temperature 75 °C, equilibrium time 40 min, and 0.8 Par. After the machine stopped, the observed precipitated powder was washed several times with water and absolute ethanol to remove solvents and any unreacted chemicals. Finally, the scarlet yellowish product was dried for 24 h under vacuum at 55 °C. For drug loading, 3 mg/mL of LD was dissolved batch-wise in ethanol which powdered CN/LD was added drop-wise under vigorous stirring for 12 h at 37 °C to prevent solvent interaction. The ratio of LD to CN/DA was equilibrated at 1:2 (W/W) ([@b0010]). Then, the suspension was centrifuged at 10.000 rpm for 45 min. The supernatant was removed and pure form of LD\@CN/DA was collected and washed again twice with ethanol, dried, and kept before use.

2.2. Physicochemical characterization {#s0020}
-------------------------------------

FTIR spectra (Model no. 4000, JASCO, Japan) spectrophotometer adjusted in range 4000--500 cm^−1^ to prove the chemical structure after the samples were mixed with KBr pellets to obtain solid disk before measure. The ^13^C NMR spectrum (BRUKER, USA) was measured and recorded at 100 MHz. High-Resolution Transmission electron microscope (HR-TEM, JEOL 2100) used to affirm the CN/DA nanostructure operating at 200 keV. The CN/DA was stained before use, and then 1 mg of samples were dispersed and sonicated in ethanol for 5 min before fixed on the copper grids, dried, and examined using TEM. Malvern Instruments Ltd, UK, dynamic light scattering (DLS, Zen 1600 Malvern USA, Ltd) to measure the hydrodynamic size of green CN/DA. Scanning electron microscope (SEM, QUANTA FEG250) was used to identify the surface morphology of samples after complete drying then after, sputtered with gold before observation. SEM unit was a pendant with an external Energy Dispersive X-ray (EDX). The typical XRD patterns for phase structure were acquired on a Philips X Pert diffractometer. Alpha 300-A Atomic force microscopy (AFM) WITec, Japan, to study the surface roughness of CN/DA and synergistic LD\@CN/DA. The thermal degradation as a function of weight loss (mg) was measured by TGA analysis (AT Instrument Q500) at 20 kV and the temperature range from 10 to 800 °C. Multipurpose UV--Vis double beam spectrophotometer (Shimadzu UV-2600) was used to measure the concentration of LD.

2.3. Determination of entrapment efficiency of LD loaded CN/DA nanosystem {#s0025}
-------------------------------------------------------------------------

Firstly, it is observed that the encapsulated drug-loaded CN/DA -based nanoantibiotic system was completely soluble in phosphate buffer solution prepared at two different pH; pH 5.0 and 7.0 affirming that there is no effect for the acid or alkaline medium on the degradation of efficiency of the drug. Consequently, in the present study, the solubility was enhanced during the presence of charged nanoparticles CN/DA which is a mild condition of preparation. The drug entrapment capacity (E%) was detected by an ultrafiltration method ([@b0245]). About 5 mL of formulated LD\@CN/DA was loaded into Millipore UFC910024 Amicon Ultra Centrifugal Filter, 15 mL Capacity, 100 kDa pore size and centrifuged at 9000 rpm at room temperature for 30 min. The amount of unattached LD in the supernatant was detected spectrophotometrically at λ max 250 nm. The regression equation of Y = 0.05X + 0.0029, with correlation coefficient R^2^ = 0.998, was used to detect the unbound LD concentration values and compared with a cited calibration curve of LD in the water at different concentrations ranging from 10 to 40 µg/mL. The designed experiment was repeated thrice at least, and the following formula was used to calculate the encapsulation efficiency of LD loaded CN/DA:$$E\left( \% \right) = \frac{D_{1} - D_{0}}{D_{1}}x100$$where E%, D~1~, and D~0~ expressed the encapsulation efficiency percentage, the initial amount of LD, and the unbounded LD respectively.

2.4. *In vitro* LD release study from the nanocomposite (LD\@CN/DA) {#s0030}
-------------------------------------------------------------------

Release behavior was examined based on two main various 50 mL phosphate buffers: PBS 5.0 and 7.4 to mimic different pHs environment ([@b0035]). The resultant LD\@CN/DA was suspended in 5 mL of mentioned PBS and then dialyzed using a dialysis bag with a porosity of 8.000 to 14.400 Da against 50 mL PBS at 37 °C for 48 h in shaking incubator at 150 rpm under dark condition. The released medium was withdrawn at fixed time intervals and replenished with fresh medium. The absorbance was calculated at exactly 250 nm at time intervals by using the calibration curve of LD as reference. The release fraction from LD\@CN/DA was calculated according to the following formula:$$LDcumulativerelease\left( \% \right) = \left( \frac{A_{t}}{A_{v}} \right)X100$$where A~t~ is the amount of released LD from CN/DA nanostructure at predetermined time t, and A~v~ the amount of LD previously-loaded inside LD\@CN/DA formulation.

2.5. Antimicrobial activity assays in *vitro* study {#s0035}
---------------------------------------------------

LD, CN/DA, and LD\@CN/DA in a concentration 2 mg.mL^−1^ were prepared and tested separately for their antimicrobial activities against the provided test microbes. The test microbes used are *MRSA*, *E. Fecalis*, *S. aureus* ATCC 6538 (G + ve), *E. Coli* ATCC 25922 (G−ve), *C. albicans* ATCC 10231 (yeast) in addition to *A. Niger* NRRL A‑326 (fungus). Nutrient agar plates were used in the case of bacteria and yeast test microbes. Each plate was seeded uniformly with 0.1 mL of 10^7^--10^8^ cells/ml from bacterial and yeast test microbes. Whereas, Potato Dextrose agar plates were used to evaluate the antifungal activities. Then a cup (1 cm diameter) was made in media by gel cutter (Cork borer) in a sterile condition. Then one drop of melted agar was poured into the hole and allowed to solidify to make a base layer. After that specific amount of tested sample (100 µL) was poured into the cup. Then plates were kept at low temperature (4 °C) for 2--4 h to allow maximum diffusion. The plates were then incubated at 37 °C for 24 h for bacteria and 30 °C for 48 h in an upright position to allow maximum growth of the organisms. The antimicrobial activity was determined by detecting the diameter of the zone of inhibition expressed in millimeter (mm). The experiment was carried out more than once and the mean of reading was recorded.

2.6. *In vitro* cell culture evaluation {#s0040}
---------------------------------------

The cytocompatibility of the designed CN/DA nanostructured was investigated using human cell line PC3 (Prostate carcinoma). Before seeding, CN/DA samples with serial concentrations (200--3.125 µg/mL) were soaked in absolute ethanol for 15 min and subjected to UV light for one hour before sterilization, then soaked in PBS thrice for further complete purification. Briefly, PC3 was seeded into 48-plate and cultured in Dulbecco\'s modified Eagle\'s medium (DMEM, Gibpco) at 37 °C and the presence of a humid atmosphere involving 5% CO~2~ for one day. Afterward, the selected cell was seeded with a specific density of 5X10^3^ cells/cm^2^ onto the sterilized nanoparticles. After 5 days in an incubator, the media was removed and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was injected into each well. 150 µL of Kit-8, CCK-8 solution was used to count the cell viability on tested nanoparticle concentrations for 1, 3, and 5 days. Cell viability is defined as the percentage of viable cells compared to the total cell number and expressed as follows ([@b0225]).$$Viability\left( \% \right) = \frac{Meanopticaldensityoftestsamples}{Meanopticaldensityofthecontrol} \times 100{(n = 5)}$$

2.7. Statistical analysis {#s0045}
-------------------------

The provided data were achieved in triplicate and expressed as mean ± the standard deviation (SD, n = 3). The significant difference analysis was determined using analysis of variance (ANOVA) via Minitab software (version 19.1.1.0). The level of P \< 0.05 is the statistical significant bar.

3. Results and discussion {#s0050}
=========================

3.1. Structural, morphological, and topography analysis {#s0055}
-------------------------------------------------------

### 3.1.1. UV--Vis detection {#s0060}

[Fig. 1](#f0005){ref-type="fig"} shows the electronic spectrum of the CN and CN/DA nanoparticles. CN is too far-UV chromophoric moieties, glucosamine, and N-acetyl-glucosamine; therefore, its extinction coefficients for wavelengths less than 250 nm are due to its transparency. The reaction between CN and DA showed a wide band at position 335 nm owing to n → π\* transition in --NH groups. In addition, the presence of aromatic nucleus indicates π → π\* allowed transition of NO~2~, C = N chromophoric groups that are conjugated with polysaccharide structure ([@b0005], [@b0040]). Also, the UV scan of LD was detected and showed the absorption maxima at exactly 250 nm.Fig. 1Absorbance spectrum of CN and CN/DA.

### 3.1.2. ^13^C NMR chemical shifts {#s0065}

The ^13^C NMR spectrum of the prepared CN/DA is shown in [Fig. 2](#f0010){ref-type="fig"}. The chemical shifts of CN (C~1~-C~6~) are matching with the bases of published elsewhere ([@b0240]). The intense peak at 49.21 ppm (C~7~) ascribed to the methylenic carbon bridge of Ar-NH-CH~2~ moiety. For C8, it appeared at 129.2, and the peak at 169.23 ppm (C~9~) related to the --C = O of Aromatic-COOH function ([@b0105]). Other detected peaks from C~10~ to C~13~ appeared at 164.51, 129.11, 123.45, and 138.2 ppm in the CN/DA structure are attributed to 3,5-DA.Fig. 2Structure elucidation of CN/DA by ^13^C NMR spectrum.

### 3.1.3. FT-IR spectral analysis {#s0070}

The FTIR spectra for CN and CN/DA were performed to outline the change in their chemical structure and the produced graphs are displayed in [Fig. 3](#f0015){ref-type="fig"}. For CN, the demonstrated peak at 3473 cm^−1^ is consigned for the stretching vibration mode of both N-H and O-H groups. Meanwhile, the bands observed at 2872 cm^−1^, 2917 cm^−1^, 1590 cm^−1^, and 1378 cm^−1^ are assigned to --CH chain stretching mode, amide I, amide II (amine ν (NH~2~) tensions), and CH~3~ symmetrical angular deformation, respectively ([@b0025], [@b0030], [@b0220]). The peak that ascribed at 1089 cm^−1^ peak is owing to the absorbance of β-1--4 glycosides linkage ([@b0165]). Moving to the FTIR of CN/DA, it is observed that there are additional peaks are observed. For example, the broadband with shift location from 3455 cm^−1^ to 3394 cm^−1^ is attributed to the existence of OH groups connected C = O of DA aromatic ring. Furthermore, there is a newly formed peak at 3097 cm^−1^ which could be related to the stretching modes of --CH in the aromatic ring ([@b0195]). The newly detected band at 2359 cm^−1^ is appointed for --CH~2~ linkage between CN-CH~2~-3,5-DA ([@b0170]). Factual augmentation of --CH bond turns out to be significant since the distortion asymmetric --CH~2~ band at 1499 cm^−1^ and symmetric --CH~2~ at 1347 cm^−1^. Other intense, the observed medium and weak peaks between 703 and 1279 cm^−1^ are correlated to substituted 3,5-DA ([@b0155]). Based on these witnessed peaks, the spectrum discloses that DA functionalized CN was effectively incorporated and the suggested mechanism is obtainable in [Scheme 1](#f0060){ref-type="fig"}. From the previous ^13^C NMR and FTIR spectral data, the anticipated structure of CN/DA has been confirmed.Fig. 3FT-IR spectra of CN and CN/DA.Scheme 1Postulated sequence for the synthesis of CN/DA and the possible interaction with LD.

### 3.1.4. TEM and SEM analysis {#s0075}

To explain the particle shape of the formed nanoparticulate system, the TEM technique has been conducted. Thus, [Fig. 4](#f0020){ref-type="fig"} displays the TEM image of an eco-friendly prepared CN/DA. As shown in [Fig. 4](#f0020){ref-type="fig"}a the produced CN/DA two possible structures (violet square) with irregular shapes. In addition, it is depicted that most DA is attached to the surface of CN particles, and some of them being incorporated into the interconnected CN network. The particles have an average diameter size of 50 ± 2 nm, which in accordance with the obtained data from DLS. For clarification of the morphological structure, SEM was performed at high magnification and then implemented in [Fig. 4](#f0020){ref-type="fig"}b which demonstrates the surface of the scanned nanoparticles exhibits agglomerated spherical particles, porous, and roughness structure with clear edges. Because of the compatibility among the reactants, both spherical particles and the presence of pores structures support efficiency drug loading. Besides, the CN chain is effectively linked to DA as a biopolymer ([@b0060]). EDX spectrum has also been shown to include C, N, and O in the sample ([Fig. 4](#f0020){ref-type="fig"}c) as well as the elemental mapping ([Fig. 4](#f0020){ref-type="fig"}d) which indicates that of the nanoparticulate system revealed that N and O atoms are major constituents and evenly distributed around the backbone. [Fig. 4](#f0020){ref-type="fig"}e displays the highly crystalline material of pure LD morphology with sheets like structure and their length is more than 30 µm. It is seen that LD is effectively incorporated into the aggregated modified CN ([Fig. 4](#f0020){ref-type="fig"}f) ([@b0050], [@b0235]) which determine very different kinetics of release. Moreover, LD easily crystallizes in different polymorphs phases or an amorphous structure which beneficial in its release rate.Fig. 4(a) HR-TEM image, (b) FE-SEM morphology, (c) EDX analysis, (d) mapping area of CN/DA, (e) surface morphology of pure LD, and (f) relative LD morphology after interaction with CN/DA.

### 3.1.5. XRD crystallography {#s0080}

Typical XRD patterns are shown in [Fig. 5](#f0025){ref-type="fig"}; there is no change in the spinal structure after adding of DA to CN, assuming that this modification had no obvious effect on the crystal phase of CN. The manifest diffraction peaks at 2θ = 37.47°, 44.0°, 64.34°, and 77.54° still as it is before modification except, 2θ = 19.7° this corresponding peak was deeply broadened owing to the insertion and compatibility of DA. Therefore, the peak intensity was reduced owing to the steric hindrance effect ([@b0260]), further confirming the introduction of DA into the CN network.Fig. 5XRD crystallography of pure CN and CN/DA.

### 3.1.6. AFM topography module {#s0085}

[Fig. 6](#f0030){ref-type="fig"} shows the three-dimensional topography AFM image. The surface of CN/DA is very small nodes like grains that are arbitrarily dispersed along the surface. The calculation of average surface roughness was 54.5 nm, which consistent with size measured from HR-TEM analysis suggesting that the surface is rough. As stated in literature any increment in surface roughness is amenable for delivering adsorption saturation ([@b0115], [@b0210]). Addition of LD exhibit hairy with uniform level grooves which increased the surface area of CN/DA towards adsorption of selected antibiotics.Fig. 6AFM topography of green (a) CN/DA and (b) LD interacted with CN/DA.

### 3.1.7. Thermal stability {#s0090}

[Fig. 7](#f0035){ref-type="fig"} displays TGA and DTA curves for synthesized CN/DA collected up to a higher 800 °C under the N~2~ atmosphere. The first distinct decomposition temperature occurs at 199.68 °C (16.64%), which is higher stable than that of previously reported pristine CN ([@b0135]). The methylene linkages are responsible for such stability, and complete decomposition from 600 °C has been attributed to the deterioration of the aromatic DA ring and the loss of the polysaccharide ring.Fig. 7TGA-DTA thermogram of CN/DA.

3.2. *In vitro* release profile of bare LD from the CN/DA nanostructured {#s0095}
------------------------------------------------------------------------

The entrapment efficiency of LD drug-loaded the green synthesized CN/DA is a principle to determine the capability of the carrier for drug loading. The optimal entrapment potency of LD loaded into CN/DA nanostructured was found to be 95.71% at low pH. As shown in [Fig. 8](#f0040){ref-type="fig"} the two curves of the released profile under two different PBS 5.0 and 7.4 buffers via the direct dispersion technique. Regardless of the nature of both CN/DA and LD the release profile was divided into two steps. In the first stage, the LD has burst release equal to 93.13 (5.0) rather than 61.96% (7.4) in 60 min. The initial burst exists in a lot of controlled systems as the mechanism dependent on pore diffusion, surface desorption, or repulsive force between opposite charges ([@b0145]). Thereafter, the release followed by a controlled release of LD from CN/DA nanostructure where the selected LD was released continuously for up to 100 min to attain maximal 98.43% compared with 85.17% in the two PBS. This returned to the biocompatibility between nanoparticles and the drug near the surface as examined in the SEM section and also related to the more crystalline phase of LD molecules tend to encapsulate inside the nanoparticles. Indicating that this type of modification might be valid in providing drug release to some extent ([@b0120]). On the other side, pH is a crucial effect on the drug release pattern due to here the swelling parameter of the as-synthesized modified CN ([@b0025], [@b0055]). Furthermore, at low pH, the amino and carboxylic acid groups in CN/DA were protonated and extend repulsive interaction between neighboring positive charges, consequently swelling ability increased facilitates LD elution. In alkaline medium, the network shrank and thus, hinders the spreading of LD.Fig. 8*In vitro* drug release profile of bare LD at pH 5.0 and pH 7.4 (n = 3).

3.3. Determination of antimicrobial inhibition zone {#s0100}
---------------------------------------------------

The antimicrobial efficacy of LD, CN/DA, and LD\@CN/DA as nanoantibiotic were examined using many different species of microbes such as *S. aureus*, *E. faecalis, E. coli*, *C. Albicans*, and *A. niger* as well. The evaluation was calculated via determining the inhibition zone diameter after submitting the designated compounds for analysis and the obtained data are outlined in [Table 1](#t0005){ref-type="table"} and [Fig. 9](#f0045){ref-type="fig"}. It has been depicted that the diameter (mm) of the killed microbes due to the antimicrobial effect of LD was 44 mm, 65 mm, 22 mm, 52 mm, and 25 mm for all tested microbes respectively. It has been observed that the efficacy of LD for killing or prevent the diffusion of microbes follows the order; *E. faecalis* \> *C. Albicans* \> *S. aureus* \> *A. niger* \> *E.coli* which means that *E. faecalis* more sensitive than the other tested microbes towards the effect of LD. It has been also proved that the polymer; CN/DA provided a little effect as an antimicrobial against the examined MRSA and *E. faecalis* microbes only. While the combination of LD\@CN/DA registered superior antimicrobial properties towards all tested microbes. The inhibition zone value was 54 mm, 69 mm and 54 mm, 57 mm, and 24 mm for *S. aureus*, *E. faecalis, E. coli, C. Albicans*, and *A. niger* respectively which exhibit higher value more than that of LD. Additionally, the antimicrobial investigation was extended to be evaluated against MRSA. It has been proven that LD exhibit higher antimicrobial properties equal to 55 mm against MRSA. The moderated antimicrobial properties of CN/DA have been detected against the nominated microbes; MRSA (33 mm). Meanwhile, the antimicrobial has been greatly enhanced during the utilization of nanoantibiotic against MRSA (59 mm). The greater effect for the latter nanocomposite could be attributed to the high surface area which enhances the easy penetration of the nanoparticulate system inside the walls of the tested microbes. Based on the aforementioned results, it can be concluded that the antimicrobial properties of LD\@CN/DA are greater than that of LD and CN/DA compounds.Table 1The antimicrobial activities of LD, CN/DA and LD\@CN/DA nanosystems against different test microbes.Clear zone (ϕmm)Sample nameSerial no*Aspergillus nigerCandida albicansEscherichia coliEnterococcus faecalis*MRSA*Staphylococcus aureus*25\
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3.4. Cytocompatibility of the CN/DA matrix {#s0105}
------------------------------------------

Since the prepared CN/DA was identified as biomaterials when dealing with the body, so it is expected that there is no toxicity. According to CCK-8 counting cell viability assay, CN/DA extends higher relative cell viability especially at a higher concentration which tended to positive effect to harvests 97.3% cell adhesion with PC3 after one day, providing good biocompatibility. So, introducing this type of antibacterial bio-nano functionality is important not only in the particle formation but also in the enhancement of cell interactions and protein adsorption ([@b0080], [@b0180]). Moreover, the cytotoxicity is directly proportional with the time to kill 89.4, 92.8, and 97.3% from the targeted cancer cells after 24, 48, and 72 h respectively ([Fig. 10](#f0050){ref-type="fig"}). Considering the results, the nanostructured CN/DA exerted higher cytocompatibility and non-toxicity with relative cell viabilities more than 85% which able to form an effective nanoantibiotic system and classified as cytocompatible ([@b0125]).Fig. 10Cytotoxicity assessment at higher concentration quantification post 24, 48, and 72 h treatment (*p* \< 0.05).

3.5. A suggested mechanism for the interaction between CN/DA and LD\@CN/DA with the bacterial cell membrane {#s0110}
-----------------------------------------------------------------------------------------------------------

It is well known that LD is a synthetic antibiotic belongs to a new class of antimicrobials called the oxazolidinones. The initiation process for the growth of microbes was carried out by disrupts the process due to the effect of the LD molecule. As identified, this initiation process has been prevented for the protein biosynthesis via binding at the 50S ribosomal subunit consequently inhibit the initiation phase of translation ([@b0205]). In some cases, the bacterial resistance of LD may be attributed to the high potency effect of LD against selected bacterial strain when combined with prepared nanoparticles CN/DA ([@b8000] \#146). In our work, LD\@CN/DA nanostructured composite was formed by chemical reaction of CN with DA. The chemical reaction has occurred via methylation reaction and ultimately, LD has been loaded onto the surface charged CN/DA. Moreover, the antimicrobial properties may be enhanced due to the attack of positively charged CN to the negative charge bacterial cell. Additionally, the utilization for using DA is to stabilize the formed CN and prevent its aggregation and thus, maintain its size in a very small size with good distribution and easily bring into being the death of microbial cell death ([@b0160]). Another postulate can be concluded from the generation of oxygen species and other free radicals due to the interaction of LD\@CN/DA with microorganisms. These active species destroy and stop the replication of microbes\' intracellular components via interaction with the main components of microbes such as lipids, phosphorous DNA, and sulfur proteins. Likewise, the topographical changes in the outer membrane should direct to a slight modification in the configuration of the cell structure. [Fig. 11](#f0055){ref-type="fig"} produces a topographical evaluation of aggravation between nanoantibiotic with MRSA and selected *C. Albicans* from other microbes. In [Fig. 11](#f0055){ref-type="fig"}a (dark field), the optical microscope of control polymorphic LD in highly crystalline order, with brought into contact with modified chitosan it has entrapped onto an internal and external surface ([Fig. 11](#f0055){ref-type="fig"}b light field) as discussed in SEM section. It has been noted from [Fig. 11](#f0055){ref-type="fig"}c that LD\@CN/DA exhibit small size with stable multiple layer structure. Also, it is observed that the surface of LD\@CN/DA exhibit two different nanonetwork layers due to the adsorption of LD onto the surface of CN/DA causes marginally increase in the viscosity of the solution, which in turn, leading to enlargement the produced particles with attacking bacterial cells ([@b0150]). The change in the morphological shape in the cell surface of MRSA became irregular and structural invagination alterations compared to [Fig. 11](#f0055){ref-type="fig"}c inset. Furthermore, MRSA cell membrane damage induced by nanosystems as it provokes the burst of intracellular components such as phosphates, potassium (small ions), and large molecules including DNA, RNA, and proteins. After confirming that the nanoantibiotic system had elegant activity on the MRSA, also the effect of the designed nanosystems on the membrane of *C. albicans* was studied. In [Fig. 11](#f0055){ref-type="fig"} (d-f) and after incubation of bacteria there was noticed that a great loss and disruption of bacteria membrane after three hours causing permanent death. Via obtaining the LD\@CN/DA with small size and good distribution, it is expected that such the prepared nanosystems (LD\@CN/DA) provides us a good prediction and deep thinking for the development of newer antibacterial agents that can be used in pharmaceutical industries.Fig. 11(a) Optical microscope of LD under dark field, (b) LD contact with CN/DA, (c) TEM of MRSA cell wall distortion when exposed to nanoantibiotic, (d) *C. albicans* without treatment, (e) initial contact with nanoantibiotic, and (f) complete disruption of *C. albicans* after 3-hours.

4. Conclusion {#s0115}
=============

A new design of nanoantibiotic is urgently warranted to combat against bacteria such as fatal MRSA and other microbes. The green approach of prepared CN/DA was discussed and characterized to affirm the nature of surface and availability to payload LD antibiotics. The constructed CN/DA exhibited irregular shapes with two possible structures and hairy with uniform grooves structure was obtained during interaction with LD antibiotic. The designed CD/LD scaffold release 98.43% LD under low pH within 100 min owing to the biocompatibility between nanoparticles and the drug near the surface. The inhibition diameter was 54, 54, and 24 mm, for *S. aureus*, *E. coli*, and *C. Albicans* which also tested and exhibit higher value compared to separate LD. Also, our results reveal that LD\@CN/DA induces severe damage on the MRSA bacterial cell membrane led to the loss of membrane integrity and their intracellular components followed by cell death. Besides, the cell viability was eradicated 97.3% from the PC3 carcinoma cell line after three days which registered as cytocompatible materials. We believe that the constructed synergistic LD with CN/DA has promising candidates in the field of industrial pharmacy.
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